BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25372271)

  • 1. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
    Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
    Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.
    Oh YM; Jeong BH; Woo SY; Kim SY; Kim H; Lee JH; Lim SY; Rhee CK; Yoo KH; Lee JH; Yoon HK; Sin DD; Lee SD; Kim EK; Park HY;
    Ann Am Thorac Soc; 2015 Jul; 12(7):1005-12. PubMed ID: 26010877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lessons from the Hokkaido COPD cohort study].
    Nishimura M; Makita H
    Nihon Rinsho; 2016 May; 74(5):864-8. PubMed ID: 27254960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
    Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
    Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD.
    Leivo-Korpela S; Lehtimäki L; Vuolteenaho K; Nieminen R; Kööbi L; Järvenpää R; Kankaanranta H; Saarelainen S; Moilanen E
    Respir Med; 2014 Jan; 108(1):122-8. PubMed ID: 24135487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serum levels of adiponectin and leptin in mustard lung patients.
    Rokni Yazdi H; Lari SM; Attaran D; Ayatollahi H; Mohsenizadeh A
    Hum Exp Toxicol; 2014 Jun; 33(6):574-81. PubMed ID: 24064910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
    Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
    Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between BODE index and systemic inflammatory biomarkers in COPD.
    Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
    COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for FEV
    Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.
    Ramírez-Venegas A; Sansores RH; Quintana-Carrillo RH; Velázquez-Uncal M; Hernandez-Zenteno RJ; Sánchez-Romero C; Velazquez-Montero A; Flores-Trujillo F
    Am J Respir Crit Care Med; 2014 Nov; 190(9):996-1002. PubMed ID: 25172140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
    Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
    Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
    Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of leptin and resistin levels in patients with chronic obstructive pulmonary disease.
    Kumor-Kisielewska A; Kierszniewska-Stępień D; Pietras T; Kroczyńska-Bednarek J; Kurmanowska Z; Antczak A; Górski P
    Pol Arch Med Wewn; 2013; 123(5):215-20. PubMed ID: 23611920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities.
    Minas M; Kostikas K; Papaioannou AI; Mystridou P; Karetsi E; Georgoulias P; Liakos N; Pournaras S; Gourgoulianis KI
    COPD; 2011 Dec; 8(6):414-20. PubMed ID: 22149401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
    Breyer MK; Rutten EP; Locantore NW; Watkins ML; Miller BE; Wouters EF;
    Eur J Clin Invest; 2012 Sep; 42(9):983-91. PubMed ID: 22703238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD.
    Devanarayan V; Scholand MB; Hoidal J; Leppert MF; Crackower MA; O'Neill GP; Gervais FG
    COPD; 2010 Feb; 7(1):51-8. PubMed ID: 20214463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
    Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
    Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.